Farmsintez ao Logo

Farmsintez ao

Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.

LIFE | MOEX

Overview

Corporate Details

ISIN(s):
RU000A0JR514
LEI:
Country:
Russian Federation
Address:
Kuzmolovskii Gorodskoi Poselok, Stantsiya Kapitolovo 134, 188663 Leningrad Oblast
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Farmsintez ao is a pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily consists of prescription medicines for hospital use, targeting therapeutic areas such as oncology, infectious diseases, women's health, nephrology, and orphan diseases. The company operates a GMP-compliant scientific and production complex, which includes a high-tech facility for API synthesis and a research center focused on fine organic synthesis for new drug development. Farmsintez also provides contract manufacturing and pharmaceutical development services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Farmsintez ao filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Farmsintez ao

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Farmsintez ao via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.